Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model-Reference-Cited by-同舟云学术

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model

Published:2016-02-01 Issue:2 Volume:11 Page:e0148139
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ouyang Mao,White Ethan E.,Ren Hui,Guo Qin,Zhang Ian,Gao Hang,Yanyan Song,Chen Xuebo,Weng Yiming,Da Fonseca Anna,Shah Sunny,Manuel Edwin R.,Zhang Leying,Vonderfecht Steven L.,Alizadeh Darya,Berlin Jacob M.,Badie Behnam

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;R Stupp;Lancet Oncol,2009

2. Mechanisms of malignant glioma immune resistance and sources of immunosuppression;GG Gomez;Gene therapy & molecular biology,2006

3. Mechanisms of malignant glioma immune resistance and sources of immunosuppression;GG Gomez;Gene Ther Mol Biol,2006

4. CpG oligodeoxynucleotides as immunotherapy in cancer;B Jahrsdorfer;Update Cancer Ther,2008

5. Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study;A Carpentier;Neuro-oncology,2010

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives;Advanced Therapeutics;2024-09-05

2. Advanced Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders;Advanced Healthcare Materials;2023-12-19

3. Recent progress in nanomedicines for imaging and therapy of brain tumors;Biomaterials Science;2023

4. Carbon Nanotubes-Based Anticancer Nanomedicine;Materials Horizons: From Nature to Nanomaterials;2023

5. Chemically Modified Carbon Nanotubes in Cancer Therapy;Chemically Modified Carbon Nanotubes for Commercial Applications;2022-12-23